Access the full text.
Sign up today, get DeepDyve free for 14 days.
Z. Lambert, P. Doering, E. Goldstein, W. Mccormick (1980)
Predispositions toward Generic Drug AcceptanceJournal of Consumer Research, 7
M. Friedman, J. Gould (2007)
Physicians' Attitudes toward Direct-to-Consumer Prescription Drug MarketingJournal of Medical Marketing, 7
J. Huh, L. Becker (2005)
Direct-to-consumer prescription drug advertising: understanding its consequencesInternational Journal of Advertising, 24
L. Bradley, J. Zito (1997)
Direct-to-consumer prescription drug advertising.Medical care, 35 1
Amy Handlin, Joseph Mosca, D. Forgione, D. Pitta (2003)
DTC pharmaceutical advertising: the debate’s not overJournal of Consumer Marketing, 20
Terence Shimp, R. Dyer (1979)
The Pain-Pill-Pleasure Model and Illicit Drug ConsumptionJournal of Consumer Research, 6
J. Avorn (2003)
Advertising and prescription drugs: promotion, education, and the public's health.Health affairs, Suppl Web Exclusives
S. Coney (2002)
Direct-to-Consumer Advertising of Prescription Pharmaceuticals: A Consumer Perspective from New ZealandJournal of Public Policy & Marketing, 21
M. Joseph, G. Stone, J. Haper, Emily Stockwell, K. Johnson, J. Huckaby (2005)
The Effect of Manufacturer-to-Consumer Prescription Drug Advertisements: An Exploratory InvestigationJournal of Medical Marketing, 5
M. Roth (1994)
Enhancing Consumer Involvement in Health Care: The Dynamics of Control, Empowerment, and TrustJournal of Public Policy & Marketing, 13
M. Wilkes, R. Bell, R. Kravitz (2000)
Direct-to-consumer prescription drug advertising: trends, impact, and implications.Health affairs, 19 2
Sandra Jones, J. Mullan (2006)
Older adults' perceptions and understanding of direct-to-consumer advertising.Journal of Consumer Marketing, 23
J. Hoek, Philip Gendall, J. Calfee (2004)
Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responsesInternational Journal of Advertising, 23
Ajit Menon, A. Deshpande, M. George, M. Perri (2004)
A model assessing the effectiveness of direct-toconsumer advertising: integration of concepts and measures from marketing and healthcareInternational Journal of Advertising, 23
C. DeNavas‐Walt, B.D. Proctor, C.H. Lee
US census bureau, current population reports, P60‐231
R.A. Bell, M.S. Wilkes, R.L. Kravitz
Advertisement‐induced drug requests
S. Coney
Direct‐to‐consumer advertising of pharmaceuticals: a consumer perspective from New Zealand
B. Mintzes, M. Barer, R. Kravitz, A. Kazanjian, K. Bassett, J. Lexchin, R. Evans, Richard Pan, S. Marion (2002)
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional surveyBMJ : British Medical Journal, 324
L. Basara (1996)
The Impact of a Direct-to-Consumer Prescription Medication Advertising Campaign on New Prescription VolumeTherapeutic Innovation & Regulatory Science, 30
Jaeun Shin, Sangho Moon (2005)
Direct‐to‐consumer prescription drug advertising: concerns and evidence on consumers' benefitJournal of Consumer Marketing, 22
R. Cardarelli, J. Licciardone, L. Taylor (2006)
A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: Is what they tell us important and true?BMC Family Practice, 7
M. Herzenstein, S. Misra, S. Posavac (2004)
How Consumers’ Attitudes Toward Direct-to-Consumer Advertising of Prescription Drugs Influence Ad Effectiveness, and Consumer and Physician BehaviorMarketing Letters, 15
Hugh White, Lindsey Draves, Roland Soong, C. Moore (2004)
‘Ask Your Doctor!’ Measuring the effect of direct-to-consumer communications in the world’s largest healthcare marketInternational Journal of Advertising, 23
M. Harker, D. Harker (2007)
Direct-to-Consumer Advertising of Prescription Medicines: A Systematic Review of the Evidence from the Perspective of the ConsumerJournal of Medical Marketing, 7
B. Parker, L. Delene (1998)
Direct-to-Consumer Prescription Drug Advertising: Content Analysis and Public Policy ImplicationsJournal of Pharmaceutical Marketing & Management, 12
J. Calfee (2002)
Public Policy Issues in Direct-to-Consumer Advertising of Prescription DrugsJournal of Public Policy & Marketing, 21
J. Hoek, Philip Gendall (2002)
Direct-to-Consumer Advertising down Under: An Alternative Perspective and Regulatory FrameworkJournal of Public Policy & Marketing, 21
S. Petroshius, Philip Titus, Kathryn Hatch (1995)
Physician attitudes toward pharmaceutical drug advertisingJournal of Advertising Research, 35
M. Sheffet, S. Kopp (1990)
Advertising Prescription Drugs to the Public: Headache or Relief?Journal of Public Policy & Marketing, 9
J. Lexchin, B. Mintzes (2002)
Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says NoJournal of Public Policy & Marketing, 21
Joel Davis (2000)
Riskier Than We Think? The Relationship Between Risk Statement Completeness and Perceptions of Direct to Consumer Advertised Prescription DrugsJournal of Health Communication, 5
J. Huh, D. Delorme, Leonard Reid (2004)
The Information Utility of DTC Prescription Drug AdvertisingJournalism & Mass Communication Quarterly, 81
R.A. Bell, M.S. Wilkes, R.L. Kravitz
The educational value of prescription drug print advertising
Deborah Spake, M. Joseph (2007)
Consumer opinion and effectiveness of direct‐to‐consumer advertisingJournal of Consumer Marketing, 24
J. Hoek, N. Maubach (2005)
A model for addressing stakeholders' concerns about direct‐to‐consumer advertising of prescription medicinesEuropean Journal of Marketing, 39
DeNavas-Walt Carmen, Bernadette Proctor, Jessica Smith (2008)
Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007
Purpose – The purpose of this paper is to examine consumer attitudes toward direct‐to‐consumer (DTC) advertising and whether consumer attitudes regarding these types of advertisements differ based on income. Design/methodology/approach – A sample of 168 consumers completed the survey on‐site at a pharmacy while waiting for their prescription(s) to be filled. Findings – The findings indicated that low‐income consumers were more likely than higher income customers to: report being persuaded by DTC advertising to ask for an advertised drug; go to the doctor based on symptoms described in DTC advertising; and to prefer branded medication over generic alternatives. Practical implications – The results provide useful information to policy makers and drug companies. The finding that these advertisements appear to impact lower income consumers to a greater extent than their higher‐income counterparts has both positive and negative implications. On the positive side, these ads appear to influence unhealthy, low‐income consumers to seek medical treatment. The negative implication concerns the effectiveness of DTC advertising in persuading low‐income consumer to prefer more expensive, branded drugs over generic alternatives. Originality/value – Limited research has been done on the relationship between consumer perceptions of DTC advertising and differences in consumer groups based on income.
International Journal of Pharmaceutical and Healthcare Marketing – Emerald Publishing
Published: Jun 27, 2008
Keywords: Pharmaceutical products; Advertising effectiveness; Consumer behaviour; Demographics
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.